open access

Vol 53, No 5 (2019)
Invited editorial
Published online: 2019-10-30
Submitted: 2019-09-29
Accepted: 2019-10-11
Get Citation

Searching for tics

Philip W. Tipton
DOI: 10.5603/PJNNS.a2019.0050
·
Pubmed: 31664709
·
Neurol Neurochir Pol 2019;53(5):315-316.

open access

Vol 53, No 5 (2019)
Invited editorial
Published online: 2019-10-30
Submitted: 2019-09-29
Accepted: 2019-10-11

Abstract

Introduction: In the current edition, Szejko and colleagues describe a subset of patients with Gilles de la Tourette syndrome (GTS) who had dystonic tics (DTs), which occurred more frequently in those with a greater number of tics and likely contribute to impairment. Clinical Reflections: DTs manifest as an abnormal posture that may be difficult to distinguish from other movements, such as dystonia and other tic types. Electromyography is an invaluable tool that can aid clinicians in making this important distinction.

Clinical Implications: Accurately diagnosing these movements can significantly impact treatment decisions and contribute to more homogenous research populations.

Abstract

Introduction: In the current edition, Szejko and colleagues describe a subset of patients with Gilles de la Tourette syndrome (GTS) who had dystonic tics (DTs), which occurred more frequently in those with a greater number of tics and likely contribute to impairment. Clinical Reflections: DTs manifest as an abnormal posture that may be difficult to distinguish from other movements, such as dystonia and other tic types. Electromyography is an invaluable tool that can aid clinicians in making this important distinction.

Clinical Implications: Accurately diagnosing these movements can significantly impact treatment decisions and contribute to more homogenous research populations.

Get Citation
About this article
Title

Searching for tics

Journal

Neurologia i Neurochirurgia Polska

Issue

Vol 53, No 5 (2019)

Pages

315-316

Published online

2019-10-30

DOI

10.5603/PJNNS.a2019.0050

Pubmed

31664709

Bibliographic record

Neurol Neurochir Pol 2019;53(5):315-316.

Authors

Philip W. Tipton

References (20)
  1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed (DSM-5). Washington, DC: American Psychiatric Association. ; 2013.
  2. Szejko N, Jakubczyk A, Dunalska A, et al. Dystonic tics in patients with Gilles de la Tourette syndrome. Neurol Neurochir Pol. ; 2019: In.
  3. Fahn S, Jankovic J, Hallett M. Psychogenic movement disorders. Principles and Practice of Movement Disorders. 2011: 513–527.
  4. Albanese A, Bhatia K, Bressman SB, et al. Phenomenology and classification of dystonia: a consensus update. Mov Disord. 2013; 28(7): 863–873.
  5. Kwak C, Dat Vuong K, Jankovic J. Premonitory sensory phenomenon in Tourette's syndrome. Mov Disord. 2003; 18(12): 1530–1533.
  6. Banaschewski T, Woerner W, Rothenberger A. Premonitory sensory phenomena and suppressibility of tics in Tourette syndrome: developmental aspects in children and adolescents. Dev Med Child Neurol. 2003; 45(10): 700–703.
  7. Panyakaew P, Cho HJ, Hallett M. Clinical Neurophysiological Evaluation for Simple Motor Tics. Clin Neurophysiol Pract. 2016; 1: 33–37.
  8. Jankovic J, Stone L. Dystonic tics in patients with Tourette's syndrome. Mov Disord. 1991; 6(3): 248–252.
  9. Kompoliti K, Goetz CG. Hyperkinetic movement disorders misdiagnosed as tics in Gilles de la Tourette syndrome. Mov Disord. 1998; 13(3): 477–480.
  10. Janik P, Szejko N. Aripiprazole in treatment of Gilles de la Tourette syndrome - New therapeutic option. Neurol Neurochir Pol. 2018; 52(1): 84–87.
  11. Pringsheim T, Okun MS, Müller-Vahl K, et al. Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology. 2019; 92(19): 896–906.
  12. Jankovic J. Botulinum toxin in the treatment of dystonic tics. Mov Disord. 1994; 9(3): 347–349.
  13. Vincent DA. Botulinum toxin in the management of laryngeal tics. J Voice. 2008; 22(2): 251–256.
  14. Kwak CH, Hanna PA, Jankovic J. Botulinum toxin in the treatment of tics. Arch Neurol. 2000; 57(8): 1190–1193.
  15. Leckman JF, Riddle MA, Hardin MT, et al. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry. 1989; 28(4): 566–573.
  16. Martino D, Pringsheim TM, Cavanna AE, et al. Members of the MDS Committee on Rating Scales Development. Systematic review of severity scales and screening instruments for tics: Critique and recommendations. Mov Disord. 2017; 32(3): 467–473.
  17. Stone LA, Jankovic J. The coexistence of tics and dystonia. Arch Neurol. 1991; 48(8): 862–865.
  18. Elston JS, Granje FC, Lees AJ. The relationship between eye-winking tics, frequent eye-blinking and blepharospasm. J Neurol Neurosurg Psychiatry. 1989; 52(4): 477–480.
  19. Németh AH, Mills KR, Elston JS, et al. Do the same genes predispose to Gilles de la Tourette syndrome and dystonia? Report of a new family and review of the literature. Mov Disord. 1999; 14(5): 826–831.
  20. Romstad A, Dupont E, Krag-Olsen B, et al. Dopa-responsive dystonia and Tourette syndrome in a large Danish family. Arch Neurol. 2003; 60(4): 618–622.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl